β‐Blocker Use and Mortality in COPD Patients After Myocardial Infarction: A Swedish Nationwide Observational Study

BACKGROUND: Patients with myocardial infarction (MI) and concomitant chronic obstructive pulmonary disease (COPD) constitute a high‐risk group with increased mortality. β‐Blocker therapy has been shown to reduce mortality, prevent arrhythmias, and delay heart failure development after an MI in broad...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :J Am Heart Assoc
Главные авторы: Andell, Pontus, Erlinge, David, Smith, J. Gustav, Sundström, Johan, Lindahl, Bertil, James, Stefan, Koul, Sasha
Формат: Artigo
Язык:Inglês
Опубликовано: Blackwell Publishing Ltd 2015
Предметы:
Original Research
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC4579937/
https://ncbi.nlm.nih.gov/pubmed/25854796
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1161/JAHA.114.001611
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы